PriceTargets.com logo

ReWalk Robotics - RWLK Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $3.00
  • Forecasted Upside: ∞
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 01/30/2024 12:59 AM ET
+0 (0.00%)
Get New ReWalk Robotics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RWLK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RWLK

Analyst Price Target is $3.00
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for ReWalk Robotics in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a ∞ upside from the last price of $0.00.

This chart shows the closing price for RWLK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in ReWalk Robotics. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/29/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/15/2023HC WainwrightReiterated RatingBuy ➝ Buy$3.00Low
8/10/2023HC WainwrightReiterated RatingBuy ➝ Buy$3.00Low
2/24/2023HC WainwrightReiterated RatingBuy$3.00Low
11/15/2022HC WainwrightBoost TargetBuy$2.50 ➝ $3.00Low
8/10/2022HC WainwrightLower TargetBuy$3.50 ➝ $2.50Low
5/18/2022HC WainwrightReiterated RatingBuyLow
11/12/2021HC WainwrightReiterated RatingBuy$3.50Low
8/10/2021HC WainwrightReiterated RatingBuy$3.50Medium
3/8/2021HC WainwrightBoost TargetBuy$2.50 ➝ $3.50High
3/1/2021HC WainwrightReiterated RatingBuy$2.50 ➝ $3.50Low
8/13/2020HC WainwrightLower TargetBuy$3.50 ➝ $2.50High
2/21/2020HC WainwrightLower TargetBuy$9.00 ➝ $3.50Low
11/15/2019HC WainwrightReiterated RatingBuy$9.00High
6/17/2019HC WainwrightUpgradeNeutral ➝ Buy$4.00 ➝ $9.00High
(Data available from 4/24/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2023
  • 5 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2023
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2023
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2024
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
ReWalk Robotics logo
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.94
Low: $0.64
High: $1.25

52 Week Range

Now: N/A

Volume

303,600 shs

Average Volume

541,468 shs

Market Capitalization

$63.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.3

Frequently Asked Questions

What sell-side analysts currently cover shares of ReWalk Robotics?

The following Wall Street analysts have issued research reports on ReWalk Robotics in the last year: HC Wainwright, and StockNews.com.
View the latest analyst ratings for RWLK.

What is the current price target for ReWalk Robotics?

1 Wall Street analysts have set twelve-month price targets for ReWalk Robotics in the last year. Their average twelve-month price target is $3.00. HC Wainwright has the highest price target set, predicting RWLK will reach $3.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $3.00 for ReWalk Robotics in the next year.
View the latest price targets for RWLK.

What is the current consensus analyst rating for ReWalk Robotics?

ReWalk Robotics currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RWLK will outperform the market and that investors should add to their positions of ReWalk Robotics.
View the latest ratings for RWLK.

What other companies compete with ReWalk Robotics?

Other companies that are similar to ReWalk Robotics include Aligos Therapeutics, Celularity, Entera Bio, Lantern Pharma and Eagle Pharmaceuticals. Learn More about companies similar to ReWalk Robotics.

How do I contact ReWalk Robotics' investor relations team?

ReWalk Robotics' physical mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company's listed phone number is (724) 959-0123 and its investor relations email address is [email protected]. The official website for ReWalk Robotics is www.rewalk.com. Learn More about contacing ReWalk Robotics investor relations.